(Q43739409)

26 November 2017

title

Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat. (English)

1 reference

26 November 2017

1 reference

S Genka

1

1 reference

26 November 2017

J Deutsch

2

1 reference

26 November 2017

P L Stahle

3

1 reference

26 November 2017

U H Shetty

4

1 reference

26 November 2017

V John

5

1 reference

26 November 2017

C Robinson

6

1 reference

26 November 2017

S I Rapoport

7

1 reference

26 November 2017

N H Greig

8

1 reference

26 November 2017

publication date

1 January 1990

1 reference

Cancer Chemotherapy and Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

27

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

1-7

1 reference

High-dose alkylating agent therapy: a review of clinical experiences

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Cyclophosphamide: Use in Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM 26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

Distribution and pharmacokinetics of cyclophosphamide in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689268

High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children

21 January 2018

1 reference

12 December 2020

Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys

1 reference

12 December 2020

Alkylating properties of phosphoramide mustard

1 reference

12 December 2020

Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds

1 reference

12 December 2020

Permeability of N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into tumor cells (author's transl)

1 reference

12 December 2020

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography

1 reference

12 December 2020

Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay

1 reference

12 December 2020

Mass spectrometric study of the distribution of cyclophosphamide in humans

1 reference

12 December 2020

Kinetics of protein binding determine rates of uptake of drugs by brain

1 reference

12 December 2020

Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metabolite

1 reference

12 December 2020

Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats

1 reference

12 December 2020

Microsomal activation of cyclophosphamide in vivo

1 reference

12 December 2020

Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas.

1 reference

12 December 2020

Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

1 reference

12 December 2020

Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis

1 reference

12 December 2020

Optimizing drug delivery to brain tumors

1 reference

12 December 2020

31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine

1 reference

12 December 2020

Murine neuroblastoma: further evaluation of the C1300 model with single antitumor agents

1 reference

12 December 2020

Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery

1 reference

12 December 2020

Kinetics of cyclophosphamide biotransformation in vivo

1 reference

12 December 2020

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma

1 reference

12 December 2020

Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy

1 reference

12 December 2020

Metabolism of radioactive cyclophosphamide.Animal tests and clinical studies

1 reference

12 December 2020

Osmotic opening of the blood-brain barrier to methotrexate in the rat

1 reference

12 December 2020

Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate

1 reference

12 December 2020

Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat

1 reference

12 December 2020

A biologically active metabolite of cyclophosphamide

1 reference

12 December 2020

Blood-brain barrier integrity and host responses in experimental metastatic brain tumours

1 reference

12 December 2020

[Tracer studies with radioactive-labelled cyclophosphamide in brain tumors].

1 reference

12 December 2020

Enzymatic toxicogenation of ?Activated? cyclophosphamide by 3??5? exonucleases

1 reference

12 December 2020

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide

1 reference

12 December 2020

Melphalan concentration dependent plasma protein binding in healthy humans and rats

1 reference

12 December 2020

Half-life of oxazaphosphorines in biological fluids

1 reference

12 December 2020

Metabolism of cyclophosphamide by rat hepatic microsomes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689268

1 reference

Dimensions Publication ID

26 November 2017

1050071123

0 references

1 reference